Vismed

DEVICE4 trials

Sponsors

Laboratoires Thea, Bausch & Lomb Incorporated, Santen SAS

Conditions

Dry EyeDry Eye Syndromes

Phase 3

Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome

CompletedNCT01568593

Laboratoires TheaDry Eye Syndromes

Start: 2012-03-31End: 2013-03-31Updated: 2016-04-04

Unknown Phase

A Study to Evaluate the Performance and Safety of Artelac Rebalance® Versus Vismed in the Management of Dry Eye

WithdrawnNCT01791426

Bausch & Lomb IncorporatedDry Eye

Start: 2013-05-31End: 2013-10-31Updated: 2013-10-11

3 Month Study of Alocross Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis

Active, not recruitingNCT04685109

Santen SASDry Eye Syndromes

Start: 2021-05-11End: 2026-09-30Target: 80Updated: 2025-05-21

3 Month Study of Cationorm Pro Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis

CompletedNCT04701086

Santen SASDry Eye Syndromes

Start: 2021-09-30End: 2025-04-28Updated: 2025-05-21